Fed. Circ. Finds Respironics' Apnea Patents Invalid

Law360, New York (July 8, 2011, 4:47 PM EDT) -- The Federal Circuit on Friday ruled that two Respironics Inc. patents for sleep apnea treatments were invalid as anticipated by prior art, reversing a lower court and handing a victory to accused infringer Invacare Corp.

Overturning a Pennsylvania federal court's decision, the appeals court held that Invacare had demonstrated that Respironics' patents were anticipated by a 1987 article penned by respiratory therapy specialist Magdy Younes.

On remand from an earlier appeal, the district court had concluded Invacare had not shown that the article disclosed all the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.